Memphasys Ltd (MEM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Memphasys Ltd (MEM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6482
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd, is a bio-separations company that develops and commercializes membrane technology solutions. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis and specialist membranes for the use in fertility treatments, including IVF for humans, artificial reproductive techniques for animals; and hydrogel membranes. It serves therapeutic plasma, IVF clinical, and research consumables markets. Memphasys also develops polymer membrane separation technology using polyacrylamide hydrogel membranes with electrophoresis. The company has operations in Australia, Singapore and the US. Memphasys is headquartered in Sydney, New South Wales, Australia.

Memphasys Ltd (MEM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Memphasys Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Memphasys Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Memphasys Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Memphasys Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Memphasys Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Memphasys Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Memphasys Enters into Collaboration with University of Melbourne 10
Equity Offering 11
Memphasys Raises USD0.2 Million in Private Placement of Shares 11
Memphasys Prices USD0.5 Million in Rights Offering of Shares 12
Memphasys Plans to Raise USD0.9 Million in Private Placement of Shares 13
Memphasys Raises Funds in Public Offering of Shares 14
NuSep to Raise USD2 Million in Rights Offering of Shares 15
NuSep to Raise Funds through Share Purchase Plan 16
NuSep Completes Private Placement Of Shares For US$1 Million 17
NuSep Completes Rights Offering Of Shares For US$1.7 Million 18
Debt Offering 19
Memphasys Plans to Raise USD0.2 Million in Public Offering of Notes Due 2017 19
Asset Transactions 20
Premier Biosoft Acquires ProteoIQ Business From NuSep 20
Memphasys Ltd – Key Competitors 21
Memphasys Ltd – Key Employees 22
Memphasys Ltd – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Corporate Communications 24
Jun 07, 2018: Memphasys Appoints Marjan Mikel as Non-Executive Director 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Memphasys Ltd, Medical Equipment, Key Facts, 2018 2
Memphasys Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Memphasys Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Memphasys Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Memphasys Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Memphasys Ltd, Deals By Market, 2012 to YTD 2018 8
Memphasys Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Memphasys Enters into Collaboration with University of Melbourne 10
Memphasys Raises USD0.2 Million in Private Placement of Shares 11
Memphasys Prices USD0.5 Million in Rights Offering of Shares 12
Memphasys Plans to Raise USD0.9 Million in Private Placement of Shares 13
Memphasys Raises Funds in Public Offering of Shares 14
NuSep to Raise USD2 Million in Rights Offering of Shares 15
NuSep to Raise Funds through Share Purchase Plan 16
NuSep Completes Private Placement Of Shares For US$1 Million 17
NuSep Completes Rights Offering Of Shares For US$1.7 Million 18
Memphasys Plans to Raise USD0.2 Million in Public Offering of Notes Due 2017 19
Premier Biosoft Acquires ProteoIQ Business From NuSep 20
Memphasys Ltd, Key Competitors 21
Memphasys Ltd, Key Employees 22

List of Figures
Memphasys Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Memphasys Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Memphasys Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Memphasys Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Memphasys Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Memphasys Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Memphasys Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Memphasys Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Memphasys Ltd (MEM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ryanair Holdings plc:企業の戦略・SWOT・財務分析
    Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Albemarle Corporation:企業の戦略・SWOT・財務情報
    Albemarle Corporation - Strategy, SWOT and Corporate Finance Report Summary Albemarle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Network Rail Ltd:企業の戦略的SWOT分析
    Network Rail Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Orpea SA (ORP):企業の財務・戦略的SWOT分析
    Summary Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse sy …
  • BioLargo Inc (BLGO):企業の財務・戦略的SWOT分析
    Summary BioLargo Inc (BioLargo) is a chemical company that offers solutions for clean water, air and wound care. The company’s products portfolio includes oxidation system, industrial odour control product, skin infection cleansers and iodine dosing system. Its oxidation system contains energised ma …
  • Empresas Copec S.A.:企業の戦略・SWOT・財務分析
    Empresas Copec S.A. - Strategy, SWOT and Corporate Finance Report Summary Empresas Copec S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ricoh Imaging Co Ltd:企業の戦略的SWOT分析
    Ricoh Imaging Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Beactica AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Beactica AB (Beactica) is a drug discovery company develops a pipeline of novel and mechanistically defined small molecule therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate ana …
  • BASF Corp:企業のM&A・事業提携・投資動向
    BASF Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BASF Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • California Physicians’ Service:企業の戦略的SWOT分析
    California Physicians' Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • China Longyuan Power Group Corp Ltd (916):企業の財務・戦略的SWOT分析
    China Longyuan Power Group Corp Ltd (916) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • WorleyParsons Ltd (WOR):石油・ガス:M&Aディール及び事業提携情報
    Summary WorleyParsons Ltd (WorleyParsons) is a provider of professional services. Its services cover the full lifecycle, from creating new assets to sustaining and enhancing operating assets. The company provides integrated solution for deepwater developments with the associated subsea, pipelines, r …
  • Yasho Industries Ltd (541167):企業の財務・戦略的SWOT分析
    Yasho Industries Ltd (541167) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Trina Solar Co Ltd:企業の戦略的SWOT分析
    Trina Solar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Tetra Technologies, Inc.:企業の戦略・SWOT・財務情報
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fujifilm Diosynth Biotechnologies USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Fujifilm Diosynth Biotechnologies USA Inc (Fujifilm Diosynth), a subsidiary of Fujifilm Corp, is a contract development and manufacturing organization that develops therapeutic products, biologics and vaccines. The organization also develops processes for molecules expressed through fermenta …
  • Modec Inc (6269):石油・ガス:M&Aディール及び事業提携情報
    Summary Modec Inc (Modec), a subsidiary of Mitsui Engineering & Shipbuilding Co., Ltd., is a general contractor specializing in engineering, procurement, construction and installation of floating production systems. It offers floating production storage and offloading (FPSO) vessels, floating storag …
  • VSB Holding GmbH-エネルギー分野:企業M&A・提携分析
    Summary VSB Holding GmbH (VSB), formerly WSB Neue Energien GmbH is a renewable energy company that offers solutions for renewable energy projects. The company offers services such as wind energy services, photovoltaics services, investments and wind park management. It provides wind energy services …
  • AFC Energy plc (AFC):企業の財務・戦略的SWOT分析
    Summary AFC Energy Plc (AFC Energy) is a developer of alkaline fuel cells. The company's projects include Power-Up and Alkammonia. Its power generation technology is used in the industrial markets and produces heat, water, and electricity. AFC Energy provides its electricity for industrial applicati …
  • Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhangzhou Pientzehuang Pharmaceutical Co Ltd (Pientzehuang), a subsidiary of Zhangzhou Jiulongjiang Construction Co Ltd, is a pharmaceutical company that manufactures and markets traditional Chinese medicines. The company develops medicines and health products, cosmetics, daily chemicals, me …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆